Inpra Pharmaceuticals Private Limited
About Inpra Pharmaceuticals Private Limited
Data last updated:
Inpra Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 24 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC301116. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anup Kumar Shahi and Rakesh Kumar Mishra.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Shop No.: 11 Yashwant Siddhi Y K Nagar Near Vihar West, Mumbai, Maharashtra, India – 401305.
As per the financials filed for FY 2020, the company reported a revenue of ₹6.49 Lakh, a growth of 147% compared to the previous year. For the same year it recorded a net profit of ₹1,435 (net margin 0.2%) and EBITDA of ₹13,138 (EBITDA margin 2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Inpra Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No.: 11 Yashwant Siddhi Y K Nagar Near Vihar West, Mumbai, Maharashtra, India – 401305
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Inpra Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inpra Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inpra Pharmaceuticals Private Limited, buy the company report.
Financials of Inpra Pharmaceuticals Private Limited
FY 2020 filings availableInpra Pharmaceuticals Private Limited reported revenue of ₹6.49 Lakh (up 147% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 147% in the latest year. EBITDA rose 237% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹6.49 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹13,138 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1,435 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Inpra Pharmaceuticals Private Limited, buy the company report.
Board of directors of Inpra Pharmaceuticals Private Limited
Inpra Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anup Kumar Shahi | Director | 24 Oct 2017 | 9 Years 0 Months | Current |
| Rakesh Kumar Mishra | Director | 24 Oct 2017 | 9 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Inpra Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inpra Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inpra Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Inpra Pharmaceuticals Private Limited, buy the company report.
Recent activity
Inpra Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anup Kumar Shahi was appointed as Director on 24 Oct 2017.
Frequently asked questions
Inpra Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 24 October 2017 (9+ years old) and is registered under CIN U51909MH2017PTC301116.
Inpra Pharmaceuticals has 2 current directors:
- Anup Kumar Shahi - Director
- Rakesh Kumar Mishra - Director
The latest financial statements of Inpra Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2018 are in the company report.
No. Inpra Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Inpra Pharmaceuticals is U51909MH2017PTC301116. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inpra Pharmaceuticals was incorporated on 24 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Anup Kumar Shahi was appointed as Director on 24 Oct 2017. Rakesh Kumar Mishra was appointed as Director on 24 Oct 2017.
The registered office of Inpra Pharmaceuticals is at Shop No.: 11 Yashwant Siddhi Y K Nagar Near Vihar West, Mumbai, Maharashtra, India – 401305.
Inpra Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Inpra Pharmaceuticals is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.